The Latest Biology News And Medical NewsBiology News 2Health News 2Biology News 3Health News 3
HOME >> MEDICINE >> NEWS
First head-to-head study to compare lidoderm patch and Celebrex in treating pain

CHADDS FORD, Pa., March 31, 2005 Today at the 24th Annual Scientific Meeting of the American Pain Society, Endo Pharmaceuticals Inc. released new clinical trial data which found patients receiving either Lidoderm (lidocaine patch 5%) or Celebrex (celecoxib) 200 mg for pain associated with osteoarthritis (OA) of the knee experienced improvement in average daily pain intensity. Lidoderm is a topical analgesic patch approved by the U.S. Food and Drug Administration (FDA) in 1999 to treat the pain associated with post-herpetic neuralgia (PHN), a chronic condition resulting from nerve damage caused by shingles.

"The results of this exploratory study examining Lidoderm and Celebrex suggest that Lidoderm can alleviate the pain associated with osteoarthritis of the knee," said Alan Kivitz, M.D., of Altoona (Pa.) Center for Clinical Research. "I am encouraged by these findings since there is a critical need for new approaches to managing this type of pain."

OA affects more than 20 million Americans annually and generates more than seven million physician visits per year. If left untreated, chronic pain conditions such as OA can have significant physical, psychological and financial consequences by affecting daily functioning and quality of life.

Due to safety concerns regarding the entire COX-II inhibitor class in the fall of 2004, the sponsor of the study, Endo Pharmaceuticals Inc., voluntarily elected to prematurely halt the study prior to reaching the original enrollment target. However an analysis of data after six weeks of treatment showed that of the patients treated in the Lidoderm group (N=56), 54% experienced a 30% or greater improvement in average daily pain intensity; (studies have reported that 30% or greater reductions in pain intensity are clinically meaningful to pain patients). In the Celebrex group (N=63), 62% experienced a 30% or greater improvement in average daily pain intensity. In addition, clinically meaningfu
'"/>

Contact: Fiona Buraimoh
fiona_buraimoh@nyc.cohnwolfe.com
212-798-9512
Cohn & Wolfe
31-Mar-2005


Page: 1 2 3

Related medicine news :

1. First UK cases of previously rare disease reported in gay men
2. First mouse model for multiple system atrophy points to new treatment targets for brain diseases
3. Mayo Clinic researchers create obedient virus; First step to use measles virus against cancer
4. First US kidney cancer vaccine trial underway at Columbia
5. First new treatment for alcoholism in ten years, now available Campral(R) (acamprosate calcium)
6. First blood test to diagnose paralyzing, blinding disease
7. First US SARS vaccine trial opens at NIH
8. First-ever safety study of medical cannabis use in Canada launched
9. First solid evidence that the study of music promotes intellectual development
10. First medical test on CD gets good results
11. First proof that cutting Rx drugs due to cost harms health

Post Your Comments:
(Date:11/21/2009)..., , WASHINGTON, Nov. 21 /PRNewswire-USNew...nate voted to proceed to Senator Reid,s version of... several objectionable items included in this bill...mandates, is the government funding for elective a...ectionable. Additionally the bill provides subsidi...
(Date:11/21/2009)..., , Association Discusses Key Provisions...alth Care Reform ,, ST. CHARLES, Ill., Nov. 21...of Representatives passing the landmark Affordable...Senate moving key health reform legislation forwar...tion,s broken health care system. Today, AARP hos...
(Date:11/21/2009)..., Eric J. Hall, president...undation of America (AFA) issued the following sta...ment detection as part of the new annual wellness ...otection and Affordable Care Act" that was in...w York, NY (PRWEB) November 21, 2009 -- Eric J. Ha...
(Date:11/20/2009)..., , WASHINGTON, Nov. 20 /PRNewswire-USNe...s urging senators to modify health care reform leg...nguage regarding a health insurance individual cov...e and enforceable mandate will minimize adverse se...ating rules prescribed by the bill. ,, "The ind...
(Date:11/20/2009)..., , CHICAGO, Nov. 20 /PRNewswire-USNewswir...asked the U.S. Food and Drug Administration (FDA) ...-whitening chemicals. ,, Citing concern about ...ministered without the benefit of professional con...tion said that the application of chemically based...
Breaking Medicine News(10 mins):Health News:FRC: Senate Votes to Proceed with Abortion Funding Debacle 2Health News:AARP Hosts Rep. Bill Foster In Health Care Reform Forum 2Health News:Alzheimer's Foundation of America Applauds Inclusion of Cognitive Impairment Detection in Healthcare Reform 2Health News:Alzheimer's Foundation of America Applauds Inclusion of Cognitive Impairment Detection in Healthcare Reform 3Health News:Actuaries to Senate: Strengthen Individual Mandate 2Health News:American Dental Association Petitions FDA to Classify, Regulate Tooth-Whitening Products 2
(Date:11/20/2009)..., NEW YORK, Nov. 20 ,, Report...port is available in its catalogue. ,, Global ...tp://www.reportlinker.com/p0164741/Global-Markets-...ewswire&utm_medium=pr&utm_campaign=prnewsw...evices includes the spring loaded core needle mark...
(Date:11/20/2009)..., HOUSTON, Nov. 20 Cyber...Dan Moore, President and Chief Executive Officer, ...sent at the 21st Annual Piper Jaffray Health Care ...009 at 12:00 PM EST. The conference session and w...l be presented. Piper Jaffray will host a webcast...
(Date:11/19/2009)...ARDEE, Ireland, Nov. 19 Warner Chi...cing of its previously announced secondary offerin...to the public of $22.25 per share. The selling sh...tal Partners, DLJ Merchant Banking, J.P. Morgan Pa... Partners, L.P., certain other institutional inves...
Breaking Medicine Technology:Reportlinker Adds Global Markets for Breast Biopsy Devices 2009 2Cyberonics to Present at 21st Annual Piper Jaffray Health Care Conference 2Warner Chilcott Prices Secondary Equity Offering 2Warner Chilcott Prices Secondary Equity Offering 3Warner Chilcott Prices Secondary Equity Offering 4Sosei Announces Filing of NDA for SOH 075 28NorLevo 28R 29 29 in Japan 14286 1Resverlogix RVX 208 Second Clinical Trial Demonstrates Success on Key Reverse Cholesterol Transport Markers 14285 1Resverlogix RVX 208 Second Clinical Trial Demonstrates Success on Key Reverse Cholesterol Transport Markers 14285 2Resverlogix RVX 208 Second Clinical Trial Demonstrates Success on Key Reverse Cholesterol Transport Markers 14285 3Resverlogix RVX 208 Second Clinical Trial Demonstrates Success on Key Reverse Cholesterol Transport Markers 14285 4Resverlogix RVX 208 Second Clinical Trial Demonstrates Success on Key Reverse Cholesterol Transport Markers 14285 5Stater Bros Super Rx Pharmacies Offer Free Antibiotics 5078 1Stater Bros Super Rx Pharmacies Offer Free Antibiotics 5078 2
Other News:
...ently published third edition of the American Hear...providing further support for the new non-drug hyp...his third edition includes a new chapter which rev...re and suggests a physiological basis for the ther...
...s Hartford Faculty Scholars and will receive $100,...ing of older adults by strengthening geriatric soc...etitive, with 25 applicants and only nine scholars... years, the Faculty Scholars will conduct a resear...
BOSTON, MA--Racial and ethnic diversity in the student population is a positive influence that helps medical students work more effectively with patients of different backgrounds, according to a study
...cks the effects of nicotine in the brain....Mecamy... of cigarette smoking....A new study has found tha...t and euphoric effects of alcohol in humans, as we...ine is a central nicotinic receptor antagonist tha...
health news:Nine chosen to receive funding for geriatric social work research 2health news:Nine chosen to receive funding for geriatric social work research 3health news:Survey of medical students affirms value of student diversity 2health news:Survey of medical students affirms value of student diversity 3health news:An anti-nicotine drug reduces the rewarding effects of alcohol 2health news:An anti-nicotine drug reduces the rewarding effects of alcohol 3health news:An anti-nicotine drug reduces the rewarding effects of alcohol 4
... and the Special Supplemental Nutrition Program fo...marily funded through the Food and Nutrition Servi... have made significant strides toward eliminating ...ncome and higher-income groups. Despite this succe...
...and computer technology, Johns Hopkins University ...ols to equip the operating room of the future. The...ors treat patients more safely and effectively and...rly impossible today....The tools include a snakel...
... to predict the risk of cardiovascular disease and...nd that, even though some measurements are associa...lness for predicting risk in individuals may be li... appears in the Dec. 21 New England Journal of Med...
...egnant mums boost the hand-eye coordination of the...shed ahead of print in the Archives of Disease in ...earchers base their findings on 98 pregnant women,...or 4g of olive oil supplements daily from 20 weeks...
health news:The future of federally funded food programs -- Can they also fight obesity? 2health news:The future of federally funded food programs -- Can they also fight obesity? 3health news:Snake-like robot and steady-hand system could assist surgeons 2health news:Snake-like robot and steady-hand system could assist surgeons 3health news:Ability of biomarkers to predict risk of heart disease, stroke appears limited 2health news:Ability of biomarkers to predict risk of heart disease, stroke appears limited 3health news:Antenatal fish oil supplements boost kids' hand-eye coordination 2